Clinical Trial Update: Carboplatin Taxol Avastin in Ovarian Cancer (OVCA) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating carboplatin, paclitaxel, and bevacizumab for ovarian cancer has completed, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Avastin (bevacizumab)
• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Ovarian Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-06-01